or Try an Advanced Search...

    Technical Analysis for SLN - Silence Therapeutics Plc

    Grade Last Price % Change Price Change
    D 21.98 1.67% 0.36
    SLN closed down 2.92 percent on Thursday, April 25, 2024, on 1.54 times normal volume.
    Earnings due: May 14
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Flat
    Historical SLN trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 1.67%
    Bollinger Band Squeeze Range Contraction 1.67%
    Bollinger Band Squeeze Range Contraction -1.30%
    Upper Bollinger Band Walk Strength -1.30%
    Inside Day Range Contraction -1.30%
    Overbought Stochastic Strength -1.30%
    Bollinger Band Squeeze Range Contraction -2.35%
    BB Squeeze + Upper Band Touch Range Contraction -2.35%
    Gapped Up Strength -2.35%
    Overbought Stochastic Strength -2.35%
    Older End-of-Day Signals for SLN ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 6 hours ago
    Outside Day about 6 hours ago
    Up 3% about 6 hours ago
    Rose Above 20 DMA about 7 hours ago
    60 Minute Opening Range Breakout about 7 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SLN Chart by TradingView
    Basic chart:

    Profile

    Silence Therapeutics Plc engages in the discovery, delivery and development of ribonucleic acid (RNA) therapeutics. It develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. Its proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Acid Molecular Biology Gene Expression Genome RNA Nucleic Acids Rna Interference Molecular Genetics Gene Silencing Small Interfering Rna

    Is SLN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 12 Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?
    Apr 8 Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
    Mar 16 Analysts Are Upgrading Silence Therapeutics plc (NASDAQ:SLN) After Its Latest Results
    Mar 15 Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript
    Mar 14 Silence Therapeutics Full Year 2023 Earnings: Misses Expectations
    Mar 13 Silence Therapeutics plc (SLN) Q4 2023 Earnings Call Transcript
    Mar 13 Silence Therapeutics gains on mid-stage win for lead asset
    Mar 13 Silence Therapeutics plc 2023 Q4 - Results - Earnings Call Presentation
    Mar 13 Silence Therapeutics reports FY results
    Mar 13 Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
    See more SLN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 27.72
    52 Week Low 4.84
    Average Volume 211,134
    200-Day Moving Average 14.38
    50-Day Moving Average 23.03
    20-Day Moving Average 21.68
    10-Day Moving Average 21.92
    Average True Range 1.19
    RSI (14) 45.95
    ADX 15.4
    +DI 17.07
    -DI 22.26
    Chandelier Exit (Long, 3 ATRs) 19.62
    Chandelier Exit (Short, 3 ATRs) 23.04
    Upper Bollinger Bands 22.79
    Lower Bollinger Band 20.57
    Percent B (%b) 0.47
    BandWidth 10.26
    MACD Line -0.13
    MACD Signal Line -0.25
    MACD Histogram 0.1216
    Fundamentals Value
    Market Cap 836.04 Million
    Num Shares 38.7 Million
    EPS -1.49
    Price-to-Earnings (P/E) Ratio -14.51
    Price-to-Sales 31.82
    Price-to-Book 33.77
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 22.82
    Resistance 3 (R3) 22.91 22.61 22.62
    Resistance 2 (R2) 22.61 22.30 22.56 22.55
    Resistance 1 (R1) 22.11 22.11 21.96 22.02 22.49
    Pivot Point 21.81 21.81 21.73 21.76 21.81
    Support 1 (S1) 21.31 21.50 21.16 21.22 20.75
    Support 2 (S2) 21.01 21.31 20.96 20.69
    Support 3 (S3) 20.51 21.01 20.62
    Support 4 (S4) 20.42